CKD Flashcards

1
Q

CKD

A

progressive, irreversible kidney function decline >3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when do symptoms arise, when is dialysis needed

A

75% nephron loss
90-95% loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CKD stages

A
  1. GFR >90 (at risk)
  2. GFR 60-89 (mild)
  3. GFR 30-59 (moderate)
  4. GFR 15-29 (severe)
  5. GFR <15 (ESKD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

azotemia

A

nitrogen-based waste accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

uremia

A

azotemia with symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

creatinine

A

increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

K

A

increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

phosphate

A

increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mg

A

increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

calcium

A

decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HCO3

A

decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

arterial pH

A

decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hgb/hct

A

decreased, anemia is common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

medications/treatment for CKD

A

phosphate binders
vitamins and supplements: iron, folic acid, B12, calcitriol, calcium carbonate
erythropoietin stimulating agents: stimulate RBC production (hgb goal: 10)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

phosphate binders reactions

A

constipation, NV, itching, muscle weakness, slow/irregular pulse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what to monitor with erythropoietin stimulating agents

A

HTN
rapid wt gain
difficulty breathing
rash/hives

17
Q

FVO in CKD

A

decreased UO
edema
HF
pulmonary issues

18
Q

what needs to be monitored in FVO in CKD

A

weight (1 kg = 1L fluid)
I&O
fluid/sodium intake

19
Q

what can be given for FVO in CKD

A

furosemide (loop/lasix)
HCTZ (thiazide)

20
Q

target BP

21
Q

ace inhibitors

A

lower CV events in CKD and HTN

22
Q

CCB

A

improve GFR and renal blood flow

23
Q

thiazide diuretics

A

volume control

24
Q

patient education for CKD

A

monitor wt
BP control
DASH diet

25
nutrition
restrict protein, K, Na, Phos high cal supplement as necessary
26
other considerations with CKD
fragile bones, risk for renal osteodystrophy complex drug management hypophosphatemia risk with phosphate binders avoid Mg-based antacids anemia management with ESAs